Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 1698-1702, April 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chapekar, M. S.
Right arrow Articles by Glazer, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapekar, M. S.
Right arrow Articles by Glazer, R. I.

Potentiation of the Cytocidal Effect of Human Immune Interferon by Different Synthetic Double-Stranded RNAs in the Refractory Human Colon Carcinoma Cell Line BE

Mrunal S. Chapekar and Robert I. Glazer1

Laboratory of Biological Chemistry, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892

A human cell line BE, derived from an undifferentiated carcinoma of the colon, was studied for its response to the cytocidal effects of human immune interferon (IFN-{gamma}) alone and in combination with various double-stranded RNAs (dsRNAs). BE cells were moderately refractory to 3-day treatment with IFN-{gamma} (10 to 300 units/ml) where only 5 to 30% reduction in colony formation occurred. A similar exposure interval to polyriboinosinic·polyribocytidylic acid [poly(I)·poly(C)] (100 µg/ml) had no detectable effect on colony formation. In contrast, the lethal effect of the combination of IFN-{gamma} and poly(I)·poly(C) was synergistic and this regimen produced a 40 to 80% reduction in colony formation. The cytocidal effects of the combination of IFN-{gamma} with varying concentrations of the dsRNAs poly(I)·poly(C), polyriboadenylic·polyribouridylic acid [poly(A)·poly(U)], polyriboinosinic·polyribocytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(ICLC)], and mismatched dsRNA [rIm·r(C13, U)m] were also examined. The concentration of the dsRNAs producing a 50% decrease in cell viability in combination with IFN-{gamma} (100 units/ml) was 6 µg/ml for poly(I)·poly(C), 1 µg/ml for poly(A)·poly(U), 3 ng/ml for poly(ICLC), and 16 µg/ml for rIm·r(C13,U)m-DNA, RNA, and protein synthesis in IFN-{gamma} and poly(I)·poly(C)-treated cells were reduced in a dose-dependent manner. However, there were no changes in either (2',5')oligoadenylate concentrations or in ribosomal RNA transcription following treatment with IFN-{gamma} and poly(I)·poly(C). Thus, the synergism resulting from the combination of IFN-{gamma} and dsRNA appears to be mediated via another, as yet unknown, mechanism.

1 To whom requests for reprints should be addressed, at National Cancer Institute, Building 37, Room 5D02, Bethesda, MD 20892.

Received 10/ 2/85. Revised 12/ 9/85. Accepted 1/ 3/86.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.